Take a breath and relax. We all know your perspective - you repeat it ad nauseum on here. I put “excellent clinical trials” in quotation marks because that is your quote that you’ve probably typed a thousand times in these threads.
Why do you see it as your mission to personally respond to any post on here that isn’t a 100% ramp job? Also, the arrogance of telling a fellow holder that they aren’t listening to the direction of the company….I fully understand the direction - nothing you say is new or insightful - the question is whether they can actually pull off what you think is a foregone conclusion. Maybe that’s where the disconnect is - you’ve clearly stated you think management is irrelevant (yet the “fundamentals” are excellent…) and think the end game that you want will arrive no matter what - it’s just a matter of releasing more data and BP will be falling all over themselves to write IMU (and you) a big cheque. I hope it works out for you because you are clearly all in and have a lot riding on this….but you will need good management from here for that to occur.
btw, it’s funny that you talk about efficacy in a ph1 trial but when other posters question efficacy, your response is that it’s only a ph1 trial so it’s all safety and efficacy doesn’t matter….so which is it? Whatever suits your narrative I guess. People are always questioning the motives of so-called “downrampers” - what about the motives of those who post hundreds of times a week with nothing but ramping?
IMU Price at posting:
3.6¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)